Advanced Search

Technical Analysis for NFX - Nuformix Plc

Grade Last Price % Change Price Change
F 2.25 -2.17% -0.05
NFX closed down 2.17 percent on Friday, April 16, 2021, on 62 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
8 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical NFX trend table...
Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Signal Line Cross Bearish -2.17%
Wide Bands Range Expansion -2.17%
Oversold Stochastic Weakness -2.17%
Hammer Candlestick Bullish -4.26%
Narrow Range Bar Range Contraction -4.26%
Doji - Bullish? Reversal -4.26%
Outside Day Range Expansion -4.26%
Older End-of-Day Signals for NFX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
1.5x Volume Pace 1 day ago
Fell Below Previous Day's Low 1 day ago
Down 3% 1 day ago
Down 2% 1 day ago
Down 1% 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators Basic chart:

Profile

Nuformix PLC, formerly Levrett PLC, is a United Kingdom-based pharmaceutical development company. The Company uses cocrystal technology to develop drugs with programs in oncology supportive care and fibrosis. It uses cocrystal technology to re-engineer the crystalline form of drugs. Its clinical pipeline includes NXP001 and NXP002. Its pre-clinical pipeline includes NXP003. It is developing NXP001 for oncology supportive care. It is developing NXP002 for the treatment of multiple fibrotic diseases. NXP003 targets a mechanism understood to confer resistance to immuno-oncology, chemotherapy and radiotherapy cancer treatments.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Support Target Pharmaceutical Medicine Clinic Pipe Disease Radio Cancer Diseases Oncology Drugs Therapy Vr Resistance Crystallography Radiotherapy Chemotherapy Fibrosis Cancer Treatments Pharmaceutical Development Radiation Therapy

Is NFX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
See more NFX news...

Indicators

Indicator Value
52 Week High 6.9
52 Week Low 1.8255
Average Volume 5,887,135
200-Day Moving Average 3.08
50-Day Moving Average 2.53
20-Day Moving Average 2.45
10-Day Moving Average 2.39
Average True Range 0.26
ADX 17.94
+DI 23.07
-DI 18.60
Chandelier Exit (Long, 3 ATRs ) 2.86
Chandelier Exit (Short, 3 ATRs ) 2.87
Upper Bollinger Band 2.94
Lower Bollinger Band 1.97
Percent B (%b) 0.29
BandWidth 39.40
MACD Line -0.06
MACD Signal Line -0.05
MACD Histogram -0.008
Fundamentals Value
Market Cap 11.55 Million
Num Shares 513 Million
EPS -0.40
Price-to-Earnings (P/E) Ratio -5.63
Price-to-Sales 24.97
Price-to-Book 3.03
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.39
Resistance 3 (R3) 2.38 2.34 2.36
Resistance 2 (R2) 2.34 2.30 2.34 2.35
Resistance 1 (R1) 2.29 2.28 2.32 2.30 2.35
Pivot Point 2.25 2.25 2.26 2.25 2.25
Support 1 (S1) 2.20 2.21 2.23 2.21 2.15
Support 2 (S2) 2.16 2.19 2.16 2.15
Support 3 (S3) 2.11 2.16 2.14
Support 4 (S4) 2.12